Skip to Content

APO LET 2.5 (Letrozole 2.5 mg)

Pill imprint APO LET 2.5 has been identified as Letrozole 2.5 mg.

Letrozole is used in the treatment of female infertility; breast cancer, metastatic; breast cancer, adjuvant; breast cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Letrozole 2.5 mg APO LET 2.5
Letrozole 2.5 mg APO LET 2.5
Discount Card Promo
Letrozole
Imprint:
APO LET 2.5
Strength:
2.5 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Aromatase inhibitors
Hormones/antineoplastics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Apotex Corp.
National Drug Code (NDC):
60505-3255
Inactive Ingredients:
hydroxypropyl cellulose
hypromelloses
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol 8000
sodium starch glycolate type A potato
titanium dioxide
ferric oxide yellow
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0803 Amerisource Health Services

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide